Skip to main content
. 2017 Jan 31;26(1):1–7. doi: 10.1297/cpe.26.1

Fig. 2.

Fig. 2.

Antithyroid drug-induced adverse events (AEs). Four patients exhibited propylthiouracil (PTU)-induced AEs after switching to PTU due to methimazole (MMI)-induced AEs: one patient each with rash after MMI-induced neutropenia, mild hepatotoxicity after MMI-induced rash, antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis after MMI-induced neutropenia, and ANCA-associated vasculitis after MMI-induced arthritis.